View Older Stories View More Recent Stories
-
Morgan Stanley Reiterates Equalweight Rating on Hims and Hers (HIMS)
-
Truist Securities Reiterates Hold Rating on Hims and Hers (HIMS)
-
BofA Securities Reiterates Underperform Rating on Hims and Hers (HIMS), PT $21
-
BTIG Reiterates Buy Rating on Hims and Hers (HIMS)
-
Hims and Hers (HIMS) PT Raised to $27 at Citi, Maintains Sell 'as we await a better entry point and more details on growth outside GLP-1s'
-
After-hours movers: Zoom, Hims & Hers Health, Tempus AI, and more
-
Hims & Hers Health, Inc. (HIMS) Misses Q4 EPS by 6c, Revenue Beats, Offers Guidance
-
Hims & Hers earnings preview: BofA weighs in ahead of the report
-
Hims & Hers Health, Inc. (HIMS) call put ratio 1 call to 1.1 puts into quarter results and outlook
-
Hims & Hers Health, Inc. (HIMS) call put ratio 1 call to 1 put on active volume into quarter results
-
Piper Sandler Reiterates Neutral Rating on Hims and Hers (HIMS), PT $24
-
Analysts explain why Hims & Hers stock is crashing today
-
Hims & Hers Health, Inc. (HIMS) call put ratio 1.1 calls to 1 put amid wide price movement into quarter results
-
Today's FDA news a 'clear negative' for Hims and Hers (HIMS) - BofA Securities
-
Hims & Hers Health, Inc. (HIMS) Weakness Tied to Report FDA Says Ozempic, Wegovy Shortage Resolved
-
Hims & Hers Health (HIMS) Acquires Peptide Facility
-
Hims & Hers Health, Inc. (HIMS) call put ratio 1.2 calls to 1 put into quarter results
-
Hims & Hers Health, Inc. (HIMS) call put ratio 1 call to 1.2 puts on active option volume of 198K contracts
-
Why Morgan Stanley is cautious on Hims & Hers shares
-
Hims and Hers (HIMS) PT Raised to $21 at BofA Securities
-
Hims & Hers Health, Inc. (HIMS) options active on 349K contracts amid sharp rally
-
Hims & Hers Health (HIMS) Acquires At-Home Lab Testing Facility
-
Hims & Hers Health, Inc. (HIMS) options active on volume of 106K contracts amid wide price movement
-
Hims and Hers (HIMS) PT Raised to $68 at Canaccord Genuity
-
Hims & Hers Health, Inc. (HIMS) call put ratio 1 call to 1.5 puts with a focus on February 28 weekly puts
-
Hims and Hers (HIMS) PT Raised to $85 at BTIG
-
Hims & Hers Health, Inc. (HIMS) call put ratio 1 call to 1 put as share price up
-
Morgan Stanley Downgrades Hims and Hers (HIMS) to Equalweight
-
Hims & Hers Health, Inc. (HIMS) call put ratio 1 call to 1.1 puts with a focus on February 28 weekly 69 calls as share price up 3.9%
-
BofA Securities Reiterates Underperform Rating on Hims and Hers (HIMS), PT $18
-
Hims & Hers Health, Inc. (HIMS) call put ratio 1 call to 1 put as share price down 1.6%
-
Citi Downgrades Hims and Hers (HIMS) to Sell
-
This GLP-1 stock is likely to deliver a revenue beat: Jefferies
-
Jefferies Reiterates Hold Rating on Hims and Hers (HIMS), 'Data Points to Rev Beat in 4Q'
-
BTIG Starts Hims and Hers (HIMS) at Buy
-
Hims and Hers (HIMS) PT Raised to $31 at Needham, Top Pick for 2025 in Digital Health
-
Hims & Hers Health, Inc. (HIMS) call put ratio 1.4 calls to 1 put with focus on January 27.50 and 35 calls
-
Hims & Hers Health (HIMS) Quickly Falls 9% after FDA Says the Obesity Drug Shortage Ended
-
Hunterbrook Media is short Hims & Hers (HIMS)
-
Hims & Hers Health, Inc. (HIMS) call put ratio 1 call to 1.6 puts with focus on December 29 puts
-
Hims & Hers Health, Inc. (HIMS) option IV increases
-
Hims & Hers Health, Inc. (HIMS) call put ratio 2.2 calls to 1 puts with focus on December 32 calls
-
Hims & Hers Health, Inc. (HIMS) December IV bid on call put ratio 1.1 calls to 1 puts
-
Morgan Stanley Starts Hims and Hers (HIMS) at Overweight
-
Hims & Hers Health, Inc. (HIMS) option implied volatility near upper end of range
-
Hims & Hers Health, Inc. (HIMS) December option implied volatility elevated
-
Hims & Hers Health, Inc. (HIMS) falls 7% as Ro says it is working with Eli Lilly to streamline access to Zepbound
-
Hims & Hers Health, Inc. (HIMS) spreader active in December 21 and 26 puts
-
Hims and Hers (HIMS) PT Raised to $40 at Nephron, 'Increasing Subscriber Outlook & Target Price'
-
Hims and Hers (HIMS) PT Raised to $38 at Canaccord Genuity
